Literature DB >> 20622109

Ovarian cancer G protein-coupled receptor 1-dependent and -independent vascular actions to acidic pH in human aortic smooth muscle cells.

Jin-Peng Liu1, Mayumi Komachi, Hideaki Tomura, Chihiro Mogi, Alatangaole Damirin, Masayuki Tobo, Mutsumi Takano, Hiromi Nochi, Koichi Tamoto, Koichi Sato, Fumikazu Okajima.   

Abstract

Atherosclerosis is a chronic inflammation disease characterized by acidic micromilieu and the accumulation of numerous bioactive lipid mediators, such as lysophosphatidic acid (LPA) and prostaglandins, in the atherosclerotic lesion. Chronic acidification induced various effects on vascular smooth muscle cells, but the molecular mechanisms underlying these effects remain unknown. In this study, we examine the role of proton-sensing ovarian cancer G protein-coupled receptor 1 (OGR1) in extracellular acidification-induced regulation of cyclooxygenase (COX)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (PAI)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs). Experiments with knockdown with small interfering RNA specific to OGR1 and specific inhibitors for G proteins showed that acidification-induced COX-2 expression, PGI(2) production, and MKP-1 expression, but not PAI-1 expression and inhibition of proliferation, were dependent on OGR1 and mainly mediated by G(q/11) protein. LPA remarkably enhanced, through the LPA(1) receptor/G(i) protein, the OGR1-mediated vascular actions to acidic pH. In conclusion, acidic pH-induced vascular actions of AoSMCs can be dissected to OGR1-dependent and -independent pathways: COX-2 expression, PGI(2) production, and MKP-1 expression are mediated by OGR1, but PAI-1 expression and inhibition of proliferation are not. LPA, which is usually thought to be a proatherogenic lipid mediator, may exert antiatherogenic actions under acidic micromilieu through cross-talk between LPA(1)/G(i) protein and OGR1/G(q/11) protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20622109     DOI: 10.1152/ajpheart.00977.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  10 in total

Review 1.  The proton-sensing receptor ovarian cancer G-protein coupled receptor 1 (OGR1) in airway physiology and disease.

Authors:  Ajay P Nayak; Raymond B Penn
Journal:  Curr Opin Pharmacol       Date:  2020-04-29       Impact factor: 5.547

2.  Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65.

Authors:  Xi-Ping Huang; Joel Karpiak; Wesley K Kroeze; Hu Zhu; Xin Chen; Sheryl S Moy; Kara A Saddoris; Viktoriya D Nikolova; Martilias S Farrell; Sheng Wang; Thomas J Mangano; Deepak A Deshpande; Alice Jiang; Raymond B Penn; Jian Jin; Beverly H Koller; Terry Kenakin; Brian K Shoichet; Bryan L Roth
Journal:  Nature       Date:  2015-11-09       Impact factor: 49.962

3.  Regulation of ovarian cancer G protein-coupled receptor-1 expression and signaling.

Authors:  Ajay P Nayak; Tonio Pera; Deepak A Deshpande; James V Michael; Jennifer R Liberato; Shi Pan; Eric Tompkins; Henry P Morelli; Roslyn Yi; Nadan Wang; Raymond B Penn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-06       Impact factor: 6.011

4.  Characterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced Responses.

Authors:  Ayaka Tobo; Masayuki Tobo; Takashi Nakakura; Masashi Ebara; Hideaki Tomura; Chihiro Mogi; Dong-Soon Im; Naoya Murata; Atsushi Kuwabara; Saki Ito; Hayato Fukuda; Mitsuhiro Arisawa; Satoshi Shuto; Michio Nakaya; Hitoshi Kurose; Koichi Sato; Fumikazu Okajima
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

Review 5.  Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth.

Authors:  Nathan A Holland; Jake T Francisco; Sean C Johnson; Joshua S Morgan; Troy J Dennis; Nishitha R Gadireddy; David A Tulis
Journal:  J Cardiovasc Dev Dis       Date:  2018-01-23

Review 6.  GPR68: An Emerging Drug Target in Cancer.

Authors:  Shu Z Wiley; Krishna Sriram; Cristina Salmerón; Paul A Insel
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

7.  Clinical data analysis reveals the role of OGR1 (GPR68) in head and neck squamous cancer.

Authors:  Wenlong Zhang; Yong Han; Weisha Li; Lin Cao; Libo Yan; Chuan Qin; Ran Gao
Journal:  Animal Model Exp Med       Date:  2020-03-18

Review 8.  Acidic tumor microenvironment and pH-sensing G protein-coupled receptors.

Authors:  Calvin R Justus; Lixue Dong; Li V Yang
Journal:  Front Physiol       Date:  2013-12-05       Impact factor: 4.566

9.  Proton-sensing ovarian cancer G protein-coupled receptor 1 on dendritic cells is required for airway responses in a murine asthma model.

Authors:  Haruka Aoki; Chihiro Mogi; Takeshi Hisada; Takashi Nakakura; Yosuke Kamide; Isao Ichimonji; Hideaki Tomura; Masayuki Tobo; Koichi Sato; Hiroaki Tsurumaki; Kunio Dobashi; Tetsuya Mori; Akihiro Harada; Masanobu Yamada; Masatomo Mori; Tamotsu Ishizuka; Fumikazu Okajima
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

Review 10.  Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.